Faculty
Investigators of the CRISPR Cures for Cancer Initiative are conducting research at the intersection of genomic technologies and cellular immunotherapies at UC San Francisco, Gladstone Institutes, or the Innovative Genomics Institute at UC Berkeley.
Assistant Professor of Medicine,
UC San Francisco
President and Professor,
UCSF Helen Diller Family Comprehensive Cancer Center
Principal Investigator,
Innovative Genomics Institute
Assistant Professor of Medicine,
UC San Francisco
Affiliate Investigator,
Gladstone Institutes
.jpg)
Professor of Pharmaceutical Chemistry, UC San Francisco
Founder,
Innovative Genomics Institute
Professor of Chemistry and Molecular & Cell Biology,
UC Berkeley
Professor of Engineering,
UC Berkeley
Assistant Professor of Medicine,
UC San Francisco
Affiliate Investigator,
Gladstone Institutes
Assistant Professor of Anatomy,
UC San Francisco
Omar Khan, MD, PhD
Cellular Therapy & Transfusion Medicine Fellow, UC San Francisco
Hanqin Li, PhD
Principal Investigator,
Innovative Genomics Institute
Professor of Cellular and Molecular Pharmacology, UC San Francisco
Professor of Medicine,
UC San Francisco
Director and Senior Investigator, Gladstone-UCSF Institute of Genomic Immunology
Professor of Bioengineering,
UC Berkeley
Assistant Investigator,
Gladstone Institutes
Associate Professor of Microbiology and Immunology, UC San Francisco
Affiliate Investigator,
Gladstone Institutes
Affiliate Investigator,
Gladstone-UCSF Institute of Genomic Immunology
Professor of Chemical & Biomolecular Imaging, UC Berkeley
Assistant Professor of Laboratory Medicine, UC San Francisco
Associate Professor of Otolaryngology-Head and Neck Surgery, UC San Francisco
Associate Professor of Laboratory Medicine, UC San Francisco
Director of Therapeutic Delivery,
Innovative Genomics Institute
Associate Professor of Medicine, UC San Francisco